EPO Patents = 1

Forward Citations = 101

Loading Chart...

7 inventors (with patents filed for the assignee):

Renato T Skerlj (7 out of 28 patents)

Peter T Lansbury (7 out of 23 patents)

Elyse Marie Josee Bourque (6 out of 23 patents)

4. Andrew Charles Good (3 out of 59 patents)

5. Jianbin Zheng (1 out of 11 patents)

6. Richard B Silverman (1 out of 108 patents)

7. Dimitri Krainc (1 out of 14 patents)

8. Elyse Marie Josée Bourque (0 patent)

7 patents: Sort by Forward Citations

1. 10786508 - Substituted imidazo[1,5-A]-pyrimidines and their use in the treatment of medical disorders (2020-09-29),

2. 10751341 - Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders (2020-08-25),

3. 10570135 - Substituted pyrazolo[1,5-A]pyrimidines and their use in the treatment of medical disorders (2020-02-25),

4. 9920061 - Imidazo[1,5-A]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders (2018-03-20),

5. 9868742 - Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b] pyridazines, related compounds, and their use in the treatment of medical disorders (2018-01-16),

6. 9840510 - Pyrazolo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders (2017-12-12),

7. 9732089 - Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disorders (2017-08-15),

Company Overview

Lysosomal Therapeutics Inc. is a biotechnology company focused on the development of novel small molecules for the treatment of neurodegenerative diseases. Their proprietary technology platform targets lysosomal enzyme deficiencies, with the potential to address a variety of rare and common neurological disorders. Lysosomal Therapeutics Inc. is committed to advancing innovative therapeutics that have the potential to improve the lives of patients.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

7 Patents

#295 in Cambridge, MA

#2,305 in Massachusetts

#39,907 in US

Cambridge, MA, United States of America

Lysosomal Therapeutics Inc.

Forward Citations = 101

7 inventors:

Renato T Skerlj (7 out of 28 patents)

Peter T Lansbury (7 out of 23 patents)

Elyse Marie Josee Bourque (6 out of 23 patents)

4. Andrew Charles Good (3 out of 59 patents)

5. Jianbin Zheng (1 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Lysosomal Therapeutics Inc.. Retrieved from https://idiyas.com/company/lysosomal-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]